12:00 AM
Jul 22, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Protalix preclinical data

Protalix said PRX-110 showed improved enzyme kinetics, less sensitivity to inhibition by actin and improved ex vivo efficacy in sputum from...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >